Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04176068 · ClinicalTrials.gov registry record · Phase 1
Combined Focused Ultrasound and Calcium Hydroxylapatitie Filler for Skin Laxity and Volume Restoration
A Phase 1 study, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT04176068 is a Phase 1 study that has completed, run by University of California, Irvine. The registered enrollment target is 20 participants.
The verdict
NCT04176068, a Phase 1 study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Non-invasive treatment options such as focused ultrasound has been used with success for the treatment of skin laxity in various parts of the body including the face, neck, décolletage, arms, buttocks, thighs, and legs. With the increasing demand for greater results, researchers have started combining modalities together such as focused ultrasound and intradermal filler, with promising effects for skin laxity and volume restoration. This study aims to elucidate the efficacy and added benefits of a combination therapy using focused ultrasound (Ulthera) and calcium hydroxylapatite (Radiesse) for the treatment of skin laxity and volume restoration of the lower thighs, specifically the lower anterior third of the thigh.
Interventions
- COMBINATION_PRODUCT calcium hydroxylapatite (Radiesse) and IFUS (Ulthera)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-04-19 |
| Est. Completion | 2021-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04176068
The ClinicalTrials.gov registry entry for NCT04176068 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which calcium hydroxylapatite (Radiesse) and IFUS (Ulthera) is the first listed.
NCT04176068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04176068 about?
NCT04176068 is a clinical study titled "Combined Focused Ultrasound and Calcium Hydroxylapatitie Filler for Skin Laxity and Volume Restoration". Non-invasive treatment options such as focused ultrasound has been used with success for the treatment of skin laxity in various parts of the body including the face, neck, décolletage, arms, buttocks, thighs, and legs. With the increasing demand for greater results, researchers have started combini...
What is the current status of trial NCT04176068?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2019-04-19. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT04176068?
The interventions under investigation include: calcium hydroxylapatite (Radiesse) and IFUS (Ulthera) (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04176068?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.